Complete a performance report through the segment margin line?

Carvell Industries has gathered the following information about the actual sales revenues and expenses for its pharmaceuticals segment for the most recent year.
Sales . . . . . . . . . . . . . . . . . . . . . . . . . . .$1,106,640
Variable Cost of Goods Sold . . . . . . . . . .$165,996
Variable Operating Expenses . . . . . . . . . .$223,938
Direct Fixed Manufacturing Overhead . . . .$115,560
Direct Fixed Operating Expenses . . . . . . .$30,900
Common Fixed Expenses . . . . . . . . . . .$16,800

Budgeted data for the same time period for the pharmaceutical segment are as follows​ (all data is in​ millions):

Budgeted sales in units . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,700
Budgeted average selling price per unit . . . . . . . . . . . . . . . . . . . .$120
Variable Cost of Goods Sold per unit . . . . . . . . . . . . . . . . . . . . . . $18
Variable Operating Expenses per unit . . . . . . . . . . . . . . . . . . . . . .$26
Direct Fixed Manufacturing Overhead (in total) . . . . . . . . . . . . . . .$107,000
Direct Fixed Operating Expenses (in total) . . . . . . . . . . . . . . . . . . $30,000
Common Fixed Expenses Allocated to the Pharmaceutical Segment . . .$16,000

complete the report through the segment margin​ line